President Cyril Ramaphosa prepares to launch the Lenacapavir HIV prevention injection in Secunda, Mpumalanga.
President Cyril Ramaphosa is set to officially launch South Africa’s rollout of a new long-acting HIV prevention injection, Lenacapavir, during a high-profile event scheduled for June 5, 2026, in Secunda, Mpumalanga.
According to the Presidency, the initiative represents a major milestone in the country’s ongoing efforts to combat HIV/AIDS and reduce new infections.
“The event will take place in Secunda, Mpumalanga,” the Presidency confirmed.
The rollout of Lenacapavir, described as a twice-yearly injectable HIV prevention option, is being positioned as a significant advancement in public health strategy, strengthening biomedical prevention tools available in South Africa’s HIV response.
